Offer - Urjas Oil for just ₹ 1 X
Myelosafe Pg, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Multiple Myeloma. Myelosafe Pg also has some secondary and off-label uses. These are listed below.
The correct dosage of Myelosafe Pg depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Myelosafe Pg also has some side effects, the most common being Weakness, Sleepiness, Edema. Apart from the aforementioned side effects, Myelosafe Pg can also lead to other problems, which have been listed below. Usually, these side effects of Myelosafe Pg go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Myelosafe Pg's effect during pregnancy is Severe and Severe while nursing. Warnings related to Myelosafe Pg's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Neutropenia must refrain from the use of Myelosafe Pg since this can cause severe adverse effects. Other contraindications of Myelosafe Pg have been discussed in the sections ahead.
Drug interactions for Myelosafe Pg have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Myelosafe Pg is not safe while driving, and is not addiction.
Myelosafe Pg is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Myelosafe Pg safe for pregnant women?
Myelosafe Pg should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Myelosafe Pg safe during breastfeeding?
Myelosafe Pg should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Myelosafe Pg on the Kidneys?
Kidney can be affected by Myelosafe Pg. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Myelosafe Pg on the Liver?
Myelosafe Pg can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Myelosafe Pg on the Heart?
Myelosafe Pg may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Myelosafe Pg should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Myelosafe Pg unless your doctor advises you to do so -
Is this Myelosafe Pg habit forming or addictive?
No, there is no any evidence that Myelosafe Pg is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Myelosafe Pg. So it is best to avoid driving.
Is it safe?
Yes, but consume Myelosafe Pg only on doctor's advice.
Is it able to treat mental disorders?
Myelosafe Pg is unable to treat or cure mental disorders.
Interaction between Food and Myelosafe Pg
Taking Myelosafe Pg with food is safe.
Interaction between Alcohol and Myelosafe Pg
Due to lack of research, there is no information about the side effects of taking Myelosafe Pg with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 753-755
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Revlimid (lenalidomide)